{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:42:47Z","timestamp":1782250967113,"version":"3.54.5"},"reference-count":30,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1254\/jphs.11r11cp","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T05:21:19Z","timestamp":1329196879000},"page":"311-316","source":"Crossref","is-referenced-by-count":36,"title":["Multiple Mechanisms for the Action of Chymase Inhibitors"],"prefix":"10.1254","volume":"118","author":[{"given":"Shinji","family":"Takai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuo","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00379-5"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.10R05FM"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.179697"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.09.032"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186–188.","DOI":"10.1126\/science.2526370"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kauffman RF, Bean JS, Zimmerman KM, Brown RF, Steinberg MI. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci. 1991;49:PL223–PL228.","DOI":"10.1016\/0024-3205(91)90298-P"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Miyazaki M, Wada T, Shiota N, Takai S. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury. J Hum Hypertens. 1999;3 Suppl 1:S21–S25.","DOI":"10.1038\/sj.jhh.1000745"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.042580"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation. 1992;86:100–110.","DOI":"10.1161\/01.CIR.86.1.100"},{"key":"10","unstructured":"10 Peters S, Gotting B, Trummel M, Rust H, Brattstrom A. Valsartan for prevention of restenosis after stenting of type B2\/C lesions: the VAL-PREST trial. J Invasive Cardiol. 2001;13:93–97."},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816050-00013"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00283-6"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2007.10.004"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00535-2"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(02)01689-2"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8768"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.57"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Manning MW, Cassis LA, Huang J, Szilvassy SJ, Daugherty A. Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med. 2002;7:45–54.","DOI":"10.1191\/1358863x02vm413ra"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1161\/hc4501.099729"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(02)01998-7"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.11053FP"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.09115FP"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000074238.61967.B7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Tani K, Ogushi F, Kido H, Kawano T, Kunori Y, Kamimura T, et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol. 2000;67:585–589.","DOI":"10.1002\/jlb.67.4.585"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00672.x"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.017"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.162933"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Lucas PA, Warejcka DJ, Young HE, Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-β<\/I>1. J Surg Res. 1996;65:135–138.","DOI":"10.1006\/jsre.1996.0355"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2002.6515"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-004-2836-z"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:09:17Z","timestamp":1621436957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/118\/3\/118_11R11CP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.11r11cp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}